StonvexLoading…
StonvexStonvexStonvexCore line items from NSIT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.25B | $8.70B | $9.18B | $10.43B |
Operating Income | $334.92M | $388.58M | $419.80M | $413.70M |
Net Income | $157.35M | $249.69M | $281.31M | $280.61M |
EPS (Diluted) | $4.86 | $6.55 | $7.55 | $7.66 |
Total Assets | $9.09B | $7.45B | $6.29B | $5.11B |
Total Liabilities | $7.44B | $5.68B | $4.55B | $3.47B |
Cash & Equivalents | $358.02M | $259.23M | $268.73M | $163.64M |
Free Cash Flow OCF − CapEx | $279.31M | $586.06M | $580.28M | $27.17M |
Shares Outstanding | 31.00M | 31.78M | 32.59M | 34.01M |